|
|
|||||||
Acute Myeloid Leukemia |
* Centre de Recherche en Cancérologie de Marseille, Département dOncologie Moléculaire, Institut Paoli-Calmettes et UMR599 Inserm, Marseille, France
° Département de BioPathologie, Institut Paoli-Calmettes, Marseille, France;
# Laboratoire de Cytogénétique, Hôpital de la Timone, Marseille, France
@ Département dHématologie, Institut Paoli-Calmettes, Marseille, France
^ Service dOncologie, Hôpital Sainte-Anne, Toulon, France
Correspondence: Marie-Joëlle Mozziconacci, Départements dOncologie Moléculaire et de BioPathologie, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. Phone: international +33.4.91223447. Fax: international +33.4.91223544. E-mail: mozziconaccimj{at}marseille.fnclcc.fr
The t(8;16)(p11;p13) translocation, associated with poor prognosis acute monocytic leukemia, fuses MYST3 on chromosome region 8p11 to CBP on chromosome region 16p13. Two types of MYST3-CBP and CBP-MYST3 fusion transcripts have been identified in patients. We describe two new types of MYST3-CBP transcripts and a new primer set.
Key words: MYST3-CBP, CBP-MYST3, t(8;16), acute myeloid leukemia.
This article has been cited by other articles:
![]() |
K. Terui, T. Sato, S. Sasaki, K. Kudo, T. Kamio, and E. Ito Two novel variants of MOZ-CBP fusion transcripts in spontaneously remitted infant leukemia with t(1;16;8)(p13;p13;p11), a new variant of t(8;16)(p11;p13) Haematologica, October 1, 2008; 93(10): 1591 - 1593. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |